Reading size

PACK IN HAND · ONE-PAGE CHECK

Medicine pack check sheet

Print this sheet or fill it in before speaking with a pharmacist or clinician. Copy only what is printed on the pack in hand. The published fields below are starting points from this record, not proof that your pack is the same product.

Published record starting point

Record display name
Actonel
Generic name / active ingredient
risedronate
Dosage-form class
Dosage form and presentation as documented in the linked primary label
Route
Oral
Record reviewed
2026-08-20

Copy from the pack in hand

Source-linked reading points

  • Check ACTONEL, risedronate sodium, the exact oral tablet, stated strength per tablet, actual package and target market together. Milligrams on the package identify that tablet; they are not a web answer for how many tablets a person should take on a day or in a week.
  • The label separates different use contexts, tablet strengths and product-specific handling requirements. A shared name, related bone-health wording or similar package numbers do not make products self-combinable, alternate-day interchangeable, splittable, strength-convertible or substitutable with another bisphosphonate.
  • The label includes warnings involving upper gastrointestinal problems, low calcium, jaw-related risk, atypical fractures and kidney function. With swallowing or chest discomfort, substantial new pain, a dental/procedure plan or another concern, bring the actual pack and complete medicine list to a pharmacist or prescribing team; this page does not decide self-continuation, pause or replacement.
  • Calcium, vitamin or mineral supplements, antacid products, prescriptions and OTC medicines used alongside it all need item-by-item review in a complete medicine list. Do not turn category words such as ‘bone medicine’, ‘calcium’ or ‘stomach medicine’ into a self-directed rule for co-use, spacing, make-up use or adjustment.

Reviewed presentation examples — compare every field

  • 35 mg per tablet; 4-tablet packNDC 0430-0472-03
  • 150 mg per tablet; 1-tablet packNDC 0430-0478-01

EDITORIAL RECORD

Who prepared and checked this page

Byline
OriginDrug Content Editorial
Review role
Public primary-source verification
Last reviewed
2026-08-20
Source record
2 clickable primary-source entry points are listed with this dossier.

The review role checks source traceability, stated market, document version and product-identity fields. It is not a claim of clinical licensure, prescribing authority or individual pharmacy service. Read the editorial policy.

Search records
Enlarged public-label image